Keyphrases
Parkinson's Disease
100%
Glucocerebrosidase
100%
Alpha-synuclein (α-syn)
46%
Idiopathic Parkinson's Disease
23%
Substrate Accumulation
15%
Glucocerebrosidase Activity
15%
Disease Pathogenesis
15%
Parkinson Patients
15%
Binding Affinity
15%
Drug-like
15%
Lysosomal Activity
7%
Commercial Drugs
7%
Glucocerebrosidase mutations
7%
Structure-based Drug Design
7%
SAR Study
7%
Drug pipeline
7%
GlcCer
7%
α-synuclein Oligomers
7%
Enzyme Assay
7%
Affinity-based
7%
Chemotype
7%
Early Disease
7%
Triplication
7%
Hit Compound
7%
In Silico Screening
7%
Lewy Bodies
7%
Small Molecules
7%
Duplication
7%
Disease Onset
7%
Cognitive Decline
7%
Compound Library
7%
Cell-based
7%
Fluorescence Polarization Assay
7%
Zinc
7%
Biochemistry, Genetics and Molecular Biology
Glucocerebrosidase
100%
Glucosylceramidase
100%
Alpha-Synuclein
53%
Binding Affinity
15%
Wild Type
7%
Small Molecule
7%
Crystal Structure
7%
Animal Experiment
7%
Enzyme Activity
7%
Structure Activity Relationship
7%
Pharmacology, Toxicology and Pharmaceutical Science
Glucosylceramidase
100%
Parkinson's Disease
100%
Alpha Synuclein
53%
Drug Development
7%
Lewy Body
7%
Drug Discovery
7%
Structure Activity Relationship
7%
Bioavailability
7%
Oligomer
7%
Diseases
7%